» Articles » PMID: 23598973

Directed Neural Differentiation of Induced Pluripotent Stem Cells from Non-human Primates

Overview
Specialty Biology
Date 2013 Apr 20
PMID 23598973
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Induced pluripotent stem cells (iPS cells) are important for the future development of regenerative medicine involving autologous cell therapy. Before autologous cell therapy can be applied to human patients, suitable animal models must be developed, and in this context non-human primate models are critical. We previously characterized several lines of marmoset iPS cells derived from newborn skin fibroblasts. In the present studies, we explored methods for the directed differentiation of marmoset iPS cells in the neuroectodermal lineage. In this process we used an iterative process in which combinations of small molecules and protein factors were tested for their effects on mRNA levels of genes that are markers for the neuroectodermal lineage. This iterative process identified combinations of chemicals/factors that substantially improved the degree of marker gene expression over the initially tested combinations. This approach should be generally valuable in the directed differentiation of pluripotent cells for experimental cell therapy.

Citing Articles

Infrastructure to Support Accrual of Older Adults to National Cancer Institute Clinical Trials.

Kimmick G, Sedrak M, Williams G, McCleary N, Rosko A, Berenberg J J Natl Cancer Inst Monogr. 2022; 2022(60):151-158.

PMID: 36519814 PMC: 9753220. DOI: 10.1093/jncimonographs/lgac025.


Overcoming barriers to reprogramming and differentiation in nonhuman primate induced pluripotent stem cells.

Hemmi J, Mishra A, Hornsby P Primate Biol. 2020; 4(2):153-162.

PMID: 32110703 PMC: 7041531. DOI: 10.5194/pb-4-153-2017.


Optimization of Differentiation of Nonhuman Primate Pluripotent Cells Using a Combinatorial Approach.

Farnsworth S, Qiu Z, Mishra A, Hornsby P Methods Mol Biol. 2019; 1919:187-197.

PMID: 30656630 PMC: 6719685. DOI: 10.1007/978-1-4939-9007-8_14.


Standards for Deriving Nonhuman Primate-Induced Pluripotent Stem Cells, Neural Stem Cells and Dopaminergic Lineage.

Yang G, Hong H, Torres A, Malloy K, Choudhury G, Kim J Int J Mol Sci. 2018; 19(9).

PMID: 30227600 PMC: 6164693. DOI: 10.3390/ijms19092788.


Induced Pluripotent Stem Cell-Derived Dopaminergic Neurons from Adult Common Marmoset Fibroblasts.

Vermilyea S, Guthrie S, Meyer M, Smuga-Otto K, Braun K, Howden S Stem Cells Dev. 2017; 26(17):1225-1235.

PMID: 28635509 PMC: 5576272. DOI: 10.1089/scd.2017.0069.


References
1.
Feala J, Cortes J, Duxbury P, Piermarocchi C, McCulloch A, Paternostro G . Systems approaches and algorithms for discovery of combinatorial therapies. Wiley Interdiscip Rev Syst Biol Med. 2010; 2(2):181-193. DOI: 10.1002/wsbm.51. View

2.
Audet J . Adventures in time and space: Nonlinearity and complexity of cytokine effects on stem cell fate decisions. Biotechnol Bioeng. 2010; 106(2):173-82. DOI: 10.1002/bit.22708. View

3.
Morizane A, Doi D, Kikuchi T, Nishimura K, Takahashi J . Small-molecule inhibitors of bone morphogenic protein and activin/nodal signals promote highly efficient neural induction from human pluripotent stem cells. J Neurosci Res. 2010; 89(2):117-26. DOI: 10.1002/jnr.22547. View

4.
Rossant J . Stem cells: the magic brew. Nature. 2007; 448(7151):260-2. DOI: 10.1038/448260a. View

5.
Hu B, Weick J, Yu J, Ma L, Zhang X, Thomson J . Neural differentiation of human induced pluripotent stem cells follows developmental principles but with variable potency. Proc Natl Acad Sci U S A. 2010; 107(9):4335-40. PMC: 2840097. DOI: 10.1073/pnas.0910012107. View